These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2460774

  • 1. Selective inhibition by 4,alpha-dimethyl-m-tyramine (H77/77) and 4-methyl-alpha-ethyl-m-tyramine (H75/12) of the monoamine oxidase within serotonergic and noradrenergic neurons in the rat brain.
    Fagervall I, Kelder D, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):143-7. PubMed ID: 2460774
    [Abstract] [Full Text] [Related]

  • 2. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I, Ross SB.
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of monoamine oxidase within monoaminergic neurons in the rat brain by (E)-beta-fluoromethylene-m-tyrosine (MDL 72394).
    Fagervall I, Ross SB.
    J Neurochem; 1989 Feb; 52(2):467-71. PubMed ID: 2521360
    [Abstract] [Full Text] [Related]

  • 4. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.
    Ask AL, Fagervall I, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):79-87. PubMed ID: 6646243
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
    Fattaccini CM, Gozlan H, Hamon M.
    Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
    [Abstract] [Full Text] [Related]

  • 6. Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.
    Ask AL, Fagervall I, Jonze M, Kelder D, Nygren R, Ross SB.
    Biochem Pharmacol; 1984 Sep 15; 33(18):2839-47. PubMed ID: 6477643
    [Abstract] [Full Text] [Related]

  • 7. Selective inhibition of monoamine oxidase by p-aminosubstituted phenylalkylamines in catecholaminergic neurones.
    Ask AL, Fagervall I, Florvall L, Ross SB, Ytterborn S.
    Neuropharmacology; 1986 Jan 15; 25(1):33-40. PubMed ID: 3005903
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of monoamine oxidase in monoaminergic neurones in the rat brain by irreversible inhibitors.
    Fagervall I, Ross SB.
    Biochem Pharmacol; 1986 Apr 15; 35(8):1381-7. PubMed ID: 2870717
    [Abstract] [Full Text] [Related]

  • 9. Distribution of the two forms of monoamine oxidase within monoaminergic neurons of the guinea pig brain.
    Ross SB.
    J Neurochem; 1987 Feb 15; 48(2):609-14. PubMed ID: 3098921
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of monoamine oxidase selectively in brain monoamine nerves using the bioprecursor (E)-beta-fluoromethylene-m-tyrosine (MDL 72394), a substrate for aromatic L-amino acid decarboxylase.
    Palfreyman MG, McDonald IA, Fozard JR, Mely Y, Sleight AJ, Zreika M, Wagner J, Bey P, Lewis PJ.
    J Neurochem; 1985 Dec 15; 45(6):1850-60. PubMed ID: 3840523
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of 5-hydroxytryptamine accumulation and deamination by substituted phenylalkylamines in hypothalamic synaptosomes from normal and reserpine-pretreated rats.
    Ask AL, Ross SB.
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec 15; 336(6):591-6. PubMed ID: 2965308
    [Abstract] [Full Text] [Related]

  • 12. Identification of kaempferol as a monoamine oxidase inhibitor and potential Neuroprotectant in extracts of Ginkgo biloba leaves.
    Sloley BD, Urichuk LJ, Morley P, Durkin J, Shan JJ, Pang PK, Coutts RT.
    J Pharm Pharmacol; 2000 Apr 15; 52(4):451-9. PubMed ID: 10813558
    [Abstract] [Full Text] [Related]

  • 13. Design and early clinical evaluation of selective inhibitors of monoamine oxidase.
    Palfreyman MG, McDonald IA, Bey P, Schechter PJ, Sjoerdsma A.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 Apr 15; 12(6):967-87. PubMed ID: 3266532
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of monoamine oxidase in 5-hydroxytryptaminergic neurones by substituted p-aminophenylalkylamines.
    Ask AL, Fagervall I, Florvall L, Ross SB, Ytterborn S.
    Br J Pharmacol; 1985 Jul 15; 85(3):683-90. PubMed ID: 3861206
    [Abstract] [Full Text] [Related]

  • 15. Selective inhibition of the A form of monoamine oxidase by 4-dimethylamino-alpha-methylphenylalkylamine derivatives in the rat.
    Ask AL, Hellström W, Norrman S, Ogren SO, Ross SB.
    Neuropharmacology; 1982 Apr 15; 21(4):299-308. PubMed ID: 7088264
    [Abstract] [Full Text] [Related]

  • 16. A comparison of the pharmacological and biochemical properties of substrate-selective monoamine oxidase inhibitors.
    Christmas AJ, Coulson CJ, Maxwell DR, Riddell D.
    Br J Pharmacol; 1972 Jul 15; 45(3):490-503. PubMed ID: 5072232
    [Abstract] [Full Text] [Related]

  • 17. limited potentiation of blood pressure in response to oral tyramine by the anti-Parkinson brain selective multifunctional monoamine oxidase-AB inhibitor, M30.
    Gal S, Abassi ZA, Youdim MB.
    Neurotox Res; 2010 Aug 15; 18(2):143-50. PubMed ID: 19894083
    [Abstract] [Full Text] [Related]

  • 18. Uptake and disappearance of 4-methyl-alpha-ethylmetatyramine in relation to its releasing action on 5-hydroxytryptamine in the brain.
    Meisch JJ, Waldeck B.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Aug 15; 287(3):233-42. PubMed ID: 1171382
    [Abstract] [Full Text] [Related]

  • 19. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N, Barneoud P, Carter C, Caille D, Sontag N, Marc C, Lolivier J, Gardes A, Perron C, Le Kim A, Charieras T, Pandini M, Burnier P, Puech F, Jegham S, George P, Scatton B, Curet O.
    J Pharmacol Exp Ther; 2004 Sep 15; 310(3):1171-82. PubMed ID: 15178694
    [Abstract] [Full Text] [Related]

  • 20. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro.
    Kan JP, Steinberg R, Leclercq J, Worms P, Biziere K.
    J Neurochem; 1988 Apr 15; 50(4):1137-44. PubMed ID: 3346672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.